Clinical efficacy and biomarker analysis of neoadjuvant ...

an experimental single-arm phase II clinical trial pilot study

A commentary on 'Clinical efficacy and biomarker analysis of neoadjuvant camrelizumab plus chemotherapy for early-stage triple-negative breast ...

2002P Efficacy and biomarker analysis of neoadjuvant disitamab ...

Antibody-drug conjugates (ADCs) have shown excellent clinical benefits in advanced MIBC in recent years, but there is a lack of studies using ADCs as ...

Publisher Correction: Clinical efficacy and biomarker analysis of ...

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial-article.

Clinical efficacy and biomarker analysis of neoadjuvant ...

Results and limitations Ninety-five patients received treatment. Of them, 44% (42/95) had atezolizumab-related AEs during the neoadjuvant period (fatigue [20%], ...

Clinical efficacy and biomarker analysis of neoadjuvant ...

Antibodies targeting PD-1 or its ligand 1 PD-L1 such as atezolizumab, have great efficacy in a proportion of metastatic urothelial cancers . Biomarkers may ...

a experimental single-arm phase II clinical trial pilot study

PDF | On Mar 4, 2024, Lei Zhang and others published A commentary on "Clinical efficacy and biomarker analysis of neoadjuvant camrelizumab ...

Clinical efficacy and biomarker analysis of neoadjuvant ... - OUCI

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. https://doi.org/10.1038/s41591-019 ...

Blood biomarkers to predict the efficacy of neoadjuvant chemo ...

Clinical staging was based on the 8th edition of the tumor, node, metastasis (TNM) Classification of the International Association for the Study ...

1160P Efficacy and biomarker identification of neoadjuvant chemo ...

Clinical trial identification. NCT04324151. Legal entity responsible for the study. The authors. Funding. Has not received any ...

Re: Clinical Efficacy and Biomarker Analysis of Neoadjuvant ... - OUCI

Powles, Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial, Nat Med, № 25, с. 1706

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors ...

... clinical efficacy of neoadjuvant ICIs remains unclear. ... Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3.

Genitourinary cancer neoadjuvant therapies: current and future ...

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. Nat. Med. 2019; 25 ...

Clinical Efficacy And Biomarker Analysis Of Neoadjuvant ...

In addition to the clinical efficacy, the Abacus trial also investigated biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma. The ...

ABACUS Manuscript _Nature Medicine_08July2019 Page 1 of 21 ...

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. Thomas Powles1 ...

Publisher Correction: Clinical efficacy and biomarker analysis of ...

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (Nature ...

Safety and efficacy of anlotinib combined with taxane and lobaplatin ...

... neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study. Ann Oncol. 2019; 30:1279-1288. Full ...

Neoadjuvant chemoimmunotherapy for small cell carcinoma of the ...

Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration ... analysis of patients with ...

Efficacy and safety of camrelizumab plus apatinib during the ...

... biomarkers which can be predictive of the neoadjuvant therapy response. ... neoadjuvant therapy, the less likely patients are to relapse based on TIME analysis.

Publisher Correction: Clinical efficacy and biomarker analysis of ...

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial Online ...

The association of histopathologic features after neoadjuvant chemo ...

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab ... biomarker analyses from the IMagyn050 randomized clinical trial. Clin. Cancer ...